Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Bernard Fisher, James J. Dignam, Norman Wolmark et al. · The Lancet · 1999 · 1K citations

Surgical Oncology, Breast Oncology, Medicine +10

Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical Treatment

Todd M. Tuttle, Elizabeth B. Habermann, Erin H. Grund et al. · Journal of Clinical Oncology · 2007 · 654 citations · Full text

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Joan Houghton · The Lancet · 2003 · 593 citations

Breast Oncology, Radiation Therapy, Medicine +8

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17

Edwin R. Fisher, James J. Dignam, Elizabeth Tan-Chiu et al. · Cancer · 1999 · 501 citations

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study

Xiang Gao, Susan G. Fisher, Bahman Emami · International Journal of Radiation Oncology*Biology*Physics · 2003 · 371 citations · Full text

Second Primary Cancer, Contralateral Breast, Surgical Oncology +10